Functional Fluidics

Functional Fluidics is a certified CLIA lab founded in 2014 that specializes in standardizing clinical blood function assays to assess individual patient response, particularly for red blood cell health in Sickle Cell Disease. The company offers proprietary biomarker assays to clinical providers, pharmaceutical, academic, and biotech partners to support drug development and patient care. Their mission is to be the gold standard in red blood cell health starting with Sickle Cell Disease.

The company is located at 440 Burroughs Street, Suite 447, Detroit, MI 48202, United States, and operates a research center in Nigeria. They provide services to clinical providers, pharmaceutical and biotech companies, and academics studying blood function through baseline and crisis events. Their assays are used to quantify the effects of drugs on blood function over time and to validate claims of pain by patients.

Functional Fluidics offers a suite of proprietary cell function assays including Flow Adhesion, Mechanical Fragility, Dynamic Sickling Assay, Oxygenscan, and Osmoscan. These tests help objectively assess patient-reported outcomes and the impact on red blood cell health. The company also provides contract research services for large-scale validation studies and high-throughput cell function testing.

The company is CLIA certified, which ensures compliance with clinical laboratory standards for their proprietary biomarker assays. They emphasize that their complex tests are well-validated and supported by thought leaders with specialized staff. This certification allows them to support clinical claims and validate assumptions in drug development.

The company's website states they are striving to be the gold standard in red blood cell health, beginning with Sickle Cell Disease. They claim their unique diagnostic platforms assess the health of red blood cells and facilitate clinical studies. This focus on Sickle Cell Disease is a key differentiator mentioned in their mission statement.

Functional Fluidics provides contract research services to pharmaceutical, BioTech, and academic research companies for pre-clinical, clinical, and post-marketing research stages. They offer value-added services to accelerate clinical trials and provide insights into individual patient-level responses. Their expertise is critical for the development of personalized medical applications and red blood cell modifying therapies.

The company has a new operations center in Sub-Saharan Africa, specifically Nigeria, offering red blood cell health assays. This expansion demonstrates their commitment to growing their reach and providing services globally. They also invite investors to engage with their team as they continue their growth and expansion.

Functional Fluidics has presented new Sickle Cell Disease data at the 2025 ASH Annual Meeting in Orlando, Florida, and will present new research at ASCAT 2026 in London. They also welcomed Biopharma Leader Bert Bruce as a Senior Advisor in December 2025. These activities highlight their active engagement in the scientific community.

The company's CEO and Founder, Patrick Hines, is an ICU Physician who developed the diagnostic tools based on his experience treating patients with serious health conditions. His background as a Pediatric ICU Physician at Detroit Medical Center drives the company's mission to help people in need receive the right care. This personal story is a central part of their origin.

The company's website mentions that their proprietary lab tests are complex and require specialized staff to operate. They emphasize that their experience and strong industry relationships are key reasons to choose them. The team is described as highly knowledgeable and professional, going above and beyond to meet customer needs.

The company's website includes a section on scientific resources with peer-reviewed publications and abstracts available. They also have a blog called ELIPSIS and provide a test menu for their assays. These resources are designed to support researchers and clinicians in understanding blood function.

Functional Fluidics offers a wide variety of options for their assays, all of which are highly reliable according to reviewers. The team is described as extremely helpful and responsive, always ready to assist with questions. This level of support is a key factor in customer satisfaction.

The company's website states that they are well-positioned to address the needs of clients with large-scale validation studies. They also offer a specialized focus on red blood cell modifying therapies. This positioning allows them to provide testing solutions across the continuum of drug development.

You can reach Functional Fluidics by phone at 13133152555 or by e-mail at [email protected].

The official website of Functional Fluidics is functionalfluidics.com.